Artivion

Artivion, Inc. (NYSE: AATI) is a medical device company focused on developing and commercializing innovative solutions for patients and surgeons mainly in cardiac and vascular surgery. The company's portfolio includes implantable biological and mechanical solutions, as well as surgical sealants.

Artivion's key product areas include:

• CryoLife: Human tissue heart valves and vascular grafts.
• On-X: Mechanical heart valves.
• PerClot: Hemostatic products used to control bleeding during surgical procedures.
• BioGlue: Surgical adhesive used for tissue sealing.

The company markets its products in North America, Europe, Asia, and other international markets. Artivion's mission is to improve the quality of life for patients by providing innovative and effective medical devices that address unmet needs in cardiac and vascular surgery. The company has a long history of innovation and is committed to developing new technologies that will improve patient outcomes.